2022中国功能性消化不良诊治专家共识

2022 Expert Consensus on Diagnosis and Treatment of Functional Dyspepsia in China

功能性消化不良(FD)是消化系统常见疾病,全球人口患病率>10%。2016年罗马Ⅳ标准对FD的定义、诊断标准和分型进行了更新,近几年我国FD的基础、临床研究也取得了很大进展。为及时更新对FD的认识,规范其临床诊疗,中华医学会消化病学分会组织相关领域专家,在2015年我国FD诊治共识意见的基础上,根据国际最新进展和我国研究证据,制定2022中国FD诊治专家共识。本专家共识涉及FD的定义、发病机制、诊断和评估、药物和非药物治疗,以及难治性FD等方面的内容。

Functional dyspepsia(FD)is a common digestive system disorder with a global prevalence of more than 10%.The RomeⅣcriteria for the definition,diagnostic criteria and classification of FD were updated in 2016.In recent years,significant progress has been made in the basic and clinical research of FD in China.In order to timely update the understanding and standardize the clinical diagnosis and treatment of FD,Chinese Society of Gastroenterology of Chinese Medical Association organized experts in related fields to develop 2022 expert consensus on FD based on the consensus in 2015,and according to the latest international progress and research evidence in China.This expert consensus involves the definition,pathogenesis,diagnosis and evaluation,drug treatment,non-drug treatment of FD,and refractory FD.